Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Reference7 articles.
1. Inc L (QC): AP (2015) Arava, leflunomide tablets. Aventis Pharma Inc 1–70
2. Schultz M, Keeling SO, Katz SJ, Maksymowych WP, Eurich DT, Hall JJ (2017) Clinical effectiveness and safety of leflunomide in inflammatory arthritis: a report from the RAPPORT database with supporting patient survey. Clin Rheumatol 36:1471–1478.
https://doi.org/10.1007/s10067-017-3687-5
3. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239–245
4. Gottenberg J-E, Venancie P-Y, Mariette X (2002) Alopecia areata in a patient with rheumatoid arthritis treated with leflunomide. J Rheumatol 29:1806–1807
5. Molina Molina MI, Pinochet Paiva CM, Quezada Morales JI (2015) Alopecia areata secondary to the use of leflunomide in patients with rheumatoid arthritis: a case report and literature review. Medwave 15:e6350–e6350.
https://doi.org/10.5867/medwave.2015.11.6350
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献